Cited by 44Ion channel regulation and functionIon Channels and ReceptorsErythrocyte Function and Pathophysiology

Structural and thermodynamic framework for PIEZO1 modulation by small molecules

Open access
Jiang, Wenjuan, Wijerathne, Tharaka D., Zhang, Han, Lin, Yi-Chun, Jo, Sunhwan, Im, Wonpil, Lacroix, Jerome J., Luo, Yun L.·2023·Proceedings of the National Academy of Sciences

Published version of a preprint

Abstract

Mechanosensitive PIEZO channels constitute potential pharmacological targets for multiple clinical conditions, spurring the search for potent chemical PIEZO modulators. Among them is Yoda1, a widely used synthetic small molecule PIEZO1 activator discovered through cell-based high-throughput screening. Yoda1 is thought to bind to PIEZO1’s mechanosensory arm domain, sandwiched between two transmembrane regions near the channel pore. However, how the binding of Yoda1 to this region promotes channel activation remains elusive. Here, we first demonstrate that cross-linking PIEZO1 repeats A and B with disulfide bridges reduces the effects of Yoda1 in a redox-dependent manner, suggesting that Yoda1 acts by perturbing the contact between these repeats. Using molecular dynamics–based absolute binding free energy simulations, we next show that Yoda1 preferentially occupies a deeper, amphipathic binding site with higher affinity in PIEZO1 open state. Using Yoda1’s binding poses in open and closed states, relative binding free energy simulations were conducted in the membrane environment, recapitulating structure–activity relationships of known Yoda1 analogs. Through virtual screening of an 8 million-compound library using computed fragment maps of the Yoda1 binding site, we subsequently identified two chemical scaffolds with agonist activity toward PIEZO1. This study supports a pharmacological model in which Yoda1 activates PIEZO1 by wedging repeats A and B, providing a structural and thermodynamic framework for the rational design of PIEZO1 modulators. Beyond PIEZO channels, the three orthogonal computational approaches employed here represent a promising path toward drug discovery in highly heterogeneous membrane protein systems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2310933120

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Jiang, W., Wijerathne, T. D., Zhang, H., Lin, Y.-C., Jo, S., Im, W., Lacroix, J. J., & Luo, Y. L.
Affiliations
  • Western University of Health Sciences (US)
  • Lehigh University (US)
  • University of Maryland, Baltimore (US)
  • Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA 91766
Corresponding author
Luo, Yun L.
Venue
Proceedings of the National Academy of Sciences
Published
2023-12-07
Volume
120
Issue
50
Pages
e2310933120-e2310933120
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4389429767
Cited by
44
References
5
Citations by year
2026: 21 · 2025: 11 · 2024: 10 · 2023: 2
FWCI
3.92
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
HHS | NIH | National Institute of General Medical Sciences (GM130834, GM138472)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
  • Health Sciences › Medicine › Physiology › Erythrocyte Function and Pathophysiology
Keywords
Piezo1, mechanosensitive ion channels, Yoda1, disulfide cross-linking, absolute binding free energy, relative binding free energy, channel open and closed states, structure-activity relationship, virtual screening, fragment-based drug discovery
MeSH terms
Binding Sites, Ion Channels, Thermodynamics, Mechanotransduction, Cellular, Drug Discovery, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review